177 related articles for article (PubMed ID: 34472829)
1. Bottlebrush Polymer-Conjugated Melittin Exhibits Enhanced Antitumor Activity and Better Safety Profile.
Jia F; Chen P; Wang D; Sun Y; Ren M; Wang Y; Cao X; Zhang L; Fang Y; Tan X; Lu H; Cai J; Lu X; Zhang K
ACS Appl Mater Interfaces; 2021 Sep; 13(36):42533-42542. PubMed ID: 34472829
[TBL] [Abstract][Full Text] [Related]
2. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.
Rady I; Siddiqui IA; Rady M; Mukhtar H
Cancer Lett; 2017 Aug; 402():16-31. PubMed ID: 28536009
[TBL] [Abstract][Full Text] [Related]
3. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
Liu M; Wang H; Liu L; Wang B; Sun G
J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
[TBL] [Abstract][Full Text] [Related]
4. Application of bee venom and its main constituent melittin for cancer treatment.
Liu CC; Hao DJ; Zhang Q; An J; Zhao JJ; Chen B; Zhang LL; Yang H
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1113-1130. PubMed ID: 27677623
[TBL] [Abstract][Full Text] [Related]
5. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity.
Ye R; Zheng Y; Chen Y; Wei X; Shi S; Chen Y; Zhu W; Wang A; Yang L; Xu Y; Peng J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55902-55912. PubMed ID: 34793125
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of naturally occurring melittin peptide isoforms in two honey bee species, Apis mellifera and Apis cerana.
Park D; Jung JW; Lee MO; Lee SY; Kim B; Jin HJ; Kim J; Ahn YJ; Lee KW; Song YS; Hong S; Womack JE; Kwon HW
Peptides; 2014 Mar; 53():185-93. PubMed ID: 24512991
[TBL] [Abstract][Full Text] [Related]
7. RGD-modified lipid disks as drug carriers for tumor targeted drug delivery.
Gao J; Xie C; Zhang M; Wei X; Yan Z; Ren Y; Ying M; Lu W
Nanoscale; 2016 Apr; 8(13):7209-16. PubMed ID: 26972577
[TBL] [Abstract][Full Text] [Related]
8. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo.
Yazdian-Robati R; Arab A; Ramezani M; Rafatpanah H; Bahreyni A; Nabavinia MS; Abnous K; Taghdisi SM
Drug Dev Ind Pharm; 2019 Apr; 45(4):603-610. PubMed ID: 30633594
[TBL] [Abstract][Full Text] [Related]
9. Oxystress inducing antitumor therapeutics via tumor-targeted delivery of PEG-conjugated D-amino acid oxidase.
Fang J; Deng D; Nakamura H; Akuta T; Qin H; Iyer AK; Greish K; Maeda H
Int J Cancer; 2008 Mar; 122(5):1135-44. PubMed ID: 17990314
[TBL] [Abstract][Full Text] [Related]
10. In situ growth of a C-terminal interferon-alpha conjugate of a phospholipid polymer that outperforms PEGASYS in cancer therapy.
Hu J; Wang G; Zhao W; Gao W
J Control Release; 2016 Sep; 237():71-7. PubMed ID: 27393654
[TBL] [Abstract][Full Text] [Related]
11. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
12. Melittin suppresses HIF-1α/VEGF expression through inhibition of ERK and mTOR/p70S6K pathway in human cervical carcinoma cells.
Shin JM; Jeong YJ; Cho HJ; Park KK; Chung IK; Lee IK; Kwak JY; Chang HW; Kim CH; Moon SK; Kim WJ; Choi YH; Chang YC
PLoS One; 2013; 8(7):e69380. PubMed ID: 23936001
[TBL] [Abstract][Full Text] [Related]
13. Melittin: a lytic peptide with anticancer properties.
Gajski G; Garaj-Vrhovac V
Environ Toxicol Pharmacol; 2013 Sep; 36(2):697-705. PubMed ID: 23892471
[TBL] [Abstract][Full Text] [Related]
14. Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models.
Boccia A; Virata C; Lindner D; English N; Pathan N; Brickelmaier M; Hu X; Gardner JL; Peng L; Wang X; Zhang X; Yang L; Perron K; Yco G; Kelly R; Gamez J; Scripps T; Bennett D; Joseph IB; Baker DP
J Interferon Cytokine Res; 2017 Jan; 37(1):20-31. PubMed ID: 27835061
[TBL] [Abstract][Full Text] [Related]
15. Graphene oxide-based magnetic nanocomposites for the delivery of melittin to cervical cancer HeLa cells.
Qi J; Chen Y; Xue T; Lin Y; Huang S; Cao S; Wang X; Su Y; Lin Z
Nanotechnology; 2020 Jan; 31(6):065102. PubMed ID: 31645027
[TBL] [Abstract][Full Text] [Related]
16. Structural and thermodynamic aspects of the interaction between heparan sulfate and analogues of melittin.
Gonçalves E; Kitas E; Seelig J
Biochemistry; 2006 Mar; 45(9):3086-94. PubMed ID: 16503664
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity.
Shin MC; Min KA; Cheong H; Moon C; Huang Y; He H; Yang VC
Pharm Res; 2016 Sep; 33(9):2218-2228. PubMed ID: 27251414
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of the anticancer properties associated with bee venom and its components in glioblastoma multiforme.
Lebel AA; Kisembo MV; Soucy MN; Hébert MPA; Morin PJ; Boudreau LH
Chem Biol Interact; 2021 Sep; 347():109622. PubMed ID: 34375656
[TBL] [Abstract][Full Text] [Related]
19. Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells.
Mansour GH; El-Magd MA; Mahfouz DH; Abdelhamid IA; Mohamed MF; Ibrahim NS; Hady A Abdel Wahab A; Elzayat EM
Bioorg Chem; 2021 Nov; 116():105329. PubMed ID: 34544028
[TBL] [Abstract][Full Text] [Related]
20. Turning Toxicants into Safe Therapeutic Drugs: Cytolytic Peptide-Photosensitizer Assemblies for Optimized In Vivo Delivery of Melittin.
Jia HR; Zhu YX; Xu KF; Wu FG
Adv Healthc Mater; 2018 Aug; 7(16):e1800380. PubMed ID: 29931753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
